Christopher Lathan, MD, MS, MPH, Chief Clinical Access and Equity Officer and Founding Director Cancer Care Equity Program, Dana-Farber

Christopher Lathan, MD, MS, MPH, is the Chief Clinical Access and Equity Officer and Founding Director, Cancer Care Equity Program at Dana-Farber. He is also a clinical oncologist focused on lung cancer.   His research interests focus on leading system wide efforts to broaden access to cancer care for historically marginalized groups to reduce disparities and improved health outcomes.   The Cancer Care Equity Program is a clinical outreach program that aids in the diagnosis and treatment of cancer patients at Federally Qualified Health Centers. Dr. Lathan’s work   addresses the health disparities he’s witnessed first-hand, including interactions his family members have had with inequitable health practices.   His primary interests are centered on the effects of race, class, and access to care in cancer outcomes, and racial disparities in lung cancer treatment, differences in access to precision medicine by race and social class and equitable distribution of new treatment across historically marginalized populations. Dr. Lathan works to bridge the gap between disparities research and the realities of patient care by developing interventions to increase access to high quality care, developed in part through community engagement.